Picture archiving and communication systems (PACS) are being implemented within radiology departments, and many facilities are entering the next stage of PACS use by deploying PACS to departments outside of radiology and to other facilities Iocated at a distance, Many PACS vendors and department administrators have based cost-justification analyses on the anticipated savings from expanding PACS to these areas. However, many of these cost-savings analyses can be highly suspect in their assumptions and findings. Technology assessment (TA) at the hospital/health system level is an organized, systematic approach to examining the efficacy of a technology in relation to the health system's mission and clinical needs. It can be an organized and unifying approach to aid in the distribution of limited capital resources. As extraradiology PACS deployment is a costly endeavor, TA may be used to plan for PACS implementation throughout the enterprise. In many organizations, PACS is thought of as a radiology domain as its first uses were centered on this image-producing service. Now, as PACS technology spreads to other service areas, such as cardiology, dermatology, pathology, orthopedics, obstetrics, etc, the need to incorporate other viewpoints in a system-based PACS is necessary to avoid having independent PACS that may duplicate archives and may not communicate with each other. How to meet the diverse PACS needs of clinical services can be a challenging task; a TA program has been demonstrated to effectively handle the clinical needs, demands, and timeframes of PACS planning and support throughout hospitals and health systems. A hospitalbased TA program can assist hea]th care organizations to present PACS as a system-wide need and program rather than a radiology-based program gobbling up the capital budget. Submitting PACS to the TA review process can identify essential elements in planning and help avoid many of the pitfalls of PACS implementation and operations. Thorough cost and/or return on investment analyses, phasing decisions, workflow re-engineering, and outcomes assessment programs are a few of the issues that a TA program can address to help in the transition to a complete electronic image environment. The TA process includes clinician selection, evaluation criteria and their
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As the cost of a PACS ranges from less than $100,000 to several million dollars, finance departments generally require some justi¡ Mini-PACS for ultrasound can be implemented costeffectively, and may be relatively simple to justify based on cost savings. Conversely, incorporating cardiac nuclear medicine images, perinatology ultrasound images, and the chest images for tuberculosis screening at the nearby immigration center into a diagnostic imaging-based archive may require an investment of several million dollars. A ROI study may say that it is a feasible option, yet actual clinical success and outcomes may differ from cost savings projected by such a study.
Workflow streamlining, reduced operating expenses, and improvements in patient care have been assessed differently (or not at all). Once decisions are made to proceed with PACS, it is very difficult to return to o¡ processes, and the need for a true understanding of its impact is paramount. Unfortunately, not every PACS facility implementing a system analyzes necessary issues.
THE QUESTIONS
Are personnel reductions in the film library a true savings? Are incremental efficiencies achieved by not waiting to retrieve hard-copy images? Is productivity enhanced as technicians and physicians do not have to travel for image review? How many systems administrators are necessary to support the PACS? Can personnel actually be reduced by, as an example, 0.38 full-time equivalent (FTE) personnel in any one shift? As PACS planning programs address these issues in varying manners, there ate numerous feasibility outcomes. This variation obviates the need for a higher level analysis of the benefits of PACS to any health care institution.
At some health systems, PACS planning has expanded, to its benefit, to include or to be organized by information technology, development and marketing departments, as well as senior administration representatives. Image management is greater than a diagnostic imaging department as endoscopy, cardiology, other patient data, and other visual light-based clinical services are beginning to plan for a hard-copyless environment. The need to expand outside the radiology department for PACS planning is necessary for enterp¡ implementations of PACS.
With this expansion outside of diagnostic imaging services, many health care organizations have used a technology assessment (TA) process to evaluate the proposed PACS plan. TA processes, like ROI studies, vary. Health care provider-based TA can be thought of asa process wherein the health care provider assesses new and emerging technologies (devices, procedures, pharmaceuticals, of new services) with respect to the provider's vision and strategic mission. Provider-based TA differs from other perspectives as it is microcosmic; it is focused on determining whether the technology is suitable and appropriate for a defined community. Macrocosmic TAs, such as those performed on behalf of government, regulatory, or payer agencies, often are focused on the inherent clinical effectiveness of a technology in a broad sense. A TA of tamoxifen for the prevention of breast cancer in the general population differs from one that examines whether a dedicated stereotactic breast biopsy system in a health system's market area can affect patient outcomes in a cost-effective manner. The microcosmic TA that is performed by a health care provider--one that seeks to align its mission and vision with new and emerging technologies--evaluates costs and benefits to the community and the health system, as well as a technology's effectiveness.
The process of TA allows health care providers to make consensus judgements about what clinical technologies are best for the whole provider, rather than what is best for the clinical service. By gathering perspectives from different ¡ and focusing on the technology's fit with mission and strategy, providers can depoliticize technology decisions through the TA process. The million-doUar capital budget grab that PACS can be seen as can instead be represented asa valuable service for all clinical services when presented and evaluated through a TA committee.
TA programs have been implemented by all types of health care providers. Although initially TA was centered in academic facilities who had the resources and personnel that could commit to the process, many community-based providers and physician groups have implemented TA programs as the benefits of a system-wide evaluation have been beneficial in the scramble for limited capital budgets.
TA programs that have been effective use predetermined criteria to measure quality and outcomes. Specific arcas that are examined include the following: technology effectiveness; impact on the community health status; need for the technology; and impact on length of stay (LOS), cost of care, revenues, and other technologies Effective TA committees are generally composed of a limited number of people, with a greater representation of physicians than administrators; physician representation is essential, as the TA committee deals with patient care. The capital budgeting for new and emerging technologies should occur after TA committee review, and is most likely handled by administrators and finance representatives.
At facilities where a PACS was being considered, the TA committees have often used the feasibility analysis as the starting point for the committee's evaluation. Generally, the radiology department administrator or chairperson had managed the feasibility analysis. When PACS entered the TA arena, the TA committee strongly encouraged the PACS champion to examine additional crite¡ which each technology being evaluated by TA committees should be submitted to. These criteria are generally established early on by the
